Amgen's Preemptive Strike Survives Motion To Dismiss
In a setback for Ariad Pharmaceuticals Inc., a federal judge has denied the drug maker's motion to dismiss a lawsuit filed by Amgen Inc., ensuring the biotechnology firm's attack on an...To view the full article, register now.
Already a subscriber? Click here to view full article